Valuation Virbac

Stocks

Real-time Euronext Paris 11:18:58 28/08/2026 BST			5-day change	1st Jan Change
325.50 ^EUR	+0.77%		-1.96%	-8.95%

08-20	Cancer vaccines finally garner the spotlight
07-29	Virbac, without the alibi

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	3,584	1,927	3,035	2,651	2,995	2,706	-	-
Change	-	-46.24%	57.52%	-12.67%	13%	-9.65%	-	-
Enterprise Value (EV) ¹	3,510	1,848	2,983	2,819	3,168	2,833	2,781	2,665
Change	-	-47.37%	61.45%	-5.49%	12.37%	-10.58%	-1.82%	-4.19%
P/E	31.7x	15.8x	25x	18.3x	19.9x	15.9x	14.3x	13.1x
PBR	4.95x	2.29x	3.34x	2.54x	2.66x	2.12x	1.87x	1.66x
PEG	-	2.06x	-72.15x	0.9x	5.23x	1.2x	1.4x	1.34x
Capitalization / Revenue	3.37x	1.58x	2.43x	1.9x	2.04x	1.74x	1.64x	1.56x
EV / Revenue	3.3x	1.52x	2.39x	2.02x	2.16x	1.83x	1.69x	1.54x
EV / EBITDA	16.3x	8.27x	12.8x	9.96x	10.9x	8.99x	8.05x	7.14x
EV / EBIT	20.8x	10.1x	16.1x	12.4x	13.8x	11.2x	10x	8.8x
EV / FCF	36.5x	40.7x	50.8x	22.8x	29.7x	33.5x	23.1x	17.7x
FCF Yield	2.74%	2.46%	1.97%	4.39%	3.37%	2.99%	4.33%	5.64%
Dividend per Share ²	1.25	1.32	1.32	1.45	1.45	1.724	2.04	2.38
Rate of return	0.29%	0.58%	0.37%	0.46%	0.41%	0.53%	0.63%	0.74%
EPS ²	13.4	14.43	14.38	17.34	18	20.38	22.53	24.74
Distribution rate	9.33%	9.15%	9.18%	8.36%	8.06%	8.46%	9.05%	9.62%
Net sales ¹	1,064	1,216	1,247	1,397	1,465	1,551	1,647	1,734
EBITDA ¹	215.1	223.4	232.8	283	289.5	315.2	345.4	373.1
EBIT ¹	168.9	182.8	184.9	227.5	229.7	254	277.5	302.8
Net income ¹	113.2	122	121.3	145.3	150.9	171.1	189.5	208.5
Net Debt ¹	-73.83	-79.36	-52.36	168.5	172.8	126.7	75.16	-41.24
Reference price ²	424.50	228.00	359.50	316.50	357.50	323.00	323.00	323.00
Nbr of stocks (in thousands)	8,443	8,451	8,443	8,375	8,378	8,378	-	-
Announcement Date	22/03/22	23/03/23	19/03/24	13/03/25	17/03/26	-	-	-

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
VIRBAC	15.85x	1.83x	8.99x	0.53%	3.15B
ZOETIS INC.	13.37x	4.13x	9.8x	2.82%	31B
ELANCO ANIMAL HEALTH INCORPORATED	177.46x	2.97x	15.02x	-.--%	12.24B
BLUESTAR ADISSEO COMPANY	14.86x	1.14x	4.22x	3.31%	3.95B
JINYU BIO-TECHNOLOGY CO., LTD.	57.11x	-	-	0.63%	2.07B
VIMIAN GROUP AB	35.22x	3.98x	14.25x	-.--%	1.98B
PHIBRO ANIMAL HEALTH CORPORATION	12.45x	1.3x	7.59x	1.32%	1.48B
TIANJIN RINGPU BIO-TECHNOLOGY CO.,LTD.	17.92x	2.22x	10.66x	1.74%	1.16B
CHINA ANIMAL HUSBANDRY INDUSTRY CO., LTD.	33.9x	-	-	0.44%	1.03B
VETOQUINOL SA	14.47x	1.05x	5.08x	1.39%	959M
Average	39.26x	2.33x	9.45x	1.22%	5.9B
Weighted average by Cap.	50.34x	3.36x	10.54x	1.85%